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ABSTRACT
To develop evidence based points to consider the use of
imaging in the diagnosis and management of juvenile
idiopathic arthritis ( JIA) in clinical practice. The task
force comprised a group of paediatric rheumatologists,
rheumatologists experienced in imaging, radiologists,
methodologists and patients from nine countries. Eleven
questions on imaging in JIA were generated using a
process of discussion and consensus. Research evidence
was searched systematically for each question using
MEDLINE, EMBASE and Cochrane CENTRAL. Imaging
modalities included were conventional radiography,
ultrasound, MRI, CT, scintigraphy and positron emission
tomography. The experts used the evidence obtained
from the relevant studies to develop a set of points to
consider. The level of agreement with each point to
consider was assessed using a numerical rating scale.
A total of 13 277 references were identified from the
search process, from which 204 studies were included in
the systematic review. Nine points to consider were
produced, taking into account the heterogeneity of JIA,
the lack of normative data and consequent difficulty
identifying pathology. These encompassed the role of
imaging in making a diagnosis of JIA, detecting and
monitoring inflammation and damage, predicting
outcome and response to treatment, use of guided
therapies, progression and remission. Level of agreement
for each proposition varied according to the research
evidence and expert opinion. Nine points to consider
and a related research agenda for the role of imaging in
the management of JIA were developed using published
evidence and expert opinion.
INTRODUCTION
Juvenile idiopathic arthritis ( JIA) is a heteroge-
neous group of conditions with onset under the
age of 16 years with unknown aetiology and
persistence of symptoms for over 6 weeks.1
Imaging plays an important role in diagnosis and
monitoring of patients with JIA, but until recently
there were few studies in this area.
A European League against Rheumatism (EULAR)
—Pediatric Rheumatology European Society (PReS)
task force was convened to produce evidence and
consensus-based recommendations on the use of
imaging in the diagnosis and management of JIA in
clinical practice for use by secondary care profes-
sionals caring for children with JIA, to help define
standards of care for appropriate imaging.
METHODS
An expert group of paediatric rheumatologists,
rheumatologists with imaging expertise, radiolo-
gists, methodologists and a fellow (16 people,
representing 9 countries) participated. The task
force used a rigorous procedure as described in the
updated EULAR standardised operating proce-
dures.2 3 Full methodological details are given in
the online supplementary material S1.
At an initial meeting, members developed ques-
tions relevant to key aspects of the use of imaging
in JIA. Eleven research questions were agreed by
consensus, encompassing the role of imaging in
making a diagnosis, detecting inflammation and
damage, predicting outcome and response to treat-
ment, the use of guided treatment, monitoring
disease progression, and remission (see online
supplementary text research questions S2).
A detailed systematic search of the published litera-
ture was performed on studies involving the use of
imaging in children with JIA. Imaging modalities
included were X-ray described as conventional radi-
ography (CR), ultrasound (US), MRI, CT, scintig-
raphy and positron emission tomography. Included
studies were evaluated for risk of bias and applic-
ability using the Quality Assessment of Diagnostic
Accuracy Studies (QUADAS)-2 tool.4 Following
presentation of the literature review at a second
meeting, experts produced points to consider
(PTC) with final agreement by a process of discus-
sion and consensus. The available evidence for each
recommendation was scored according to the
Oxford Centre for Evidence-Based Medicine level
of evidence.5 The experts anonymously scored
their level of agreement for each proposition using
a 0–10 numerical rating scale (0=do not agree at
all, 10=fully agree). Scores reflected research evi-
dence and clinical expertise.2 An agenda for future
research was also agreed upon following presenta-
tion of the literature review.
Three patient representatives (one child and two
young adults with a diagnosis of JIA) and two
parents of children with JIA participated in the
development of the PTC at a Patient and Public
Involvement event; further details are given in the
online supplementary material S1.
RESULTS
The database search (November 2013) resulted in
13 277 records leaving 10 925 articles after
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deduplication. Four hundred and thirty-three articles were
included for detailed review once exclusions were made based
on title or abstract. All full text articles written in English were
retrieved for review, of which 244 articles were excluded
leaving 189 articles for inclusion. The hand search identified 15
additional articles, resulting in a total of 204 articles for inclu-
sion (see flow chart in the online supplementary figure S4).
Articles that were relevant to multiple research questions were
included in the review as necessary. The number of articles
included per question is shown in the online supplementary
table S5.
The task force produced nine PTC which are presented with
the level of evidence, grade of recommendation and level of
agreement in table 1. The task force felt that the supporting
data was not sufficient to produce ‘recommendations’ so they
were categorised as ‘points to consider’. Scores for risk of bias
and applicability of the included studies according to
QUADAS-2, a full reference list for articles included in each rec-
ommendation, and feedback given at the Patient and Public
Involvement meeting are given in the online supplementary text
S6 S7 and S8.
Overarching principles
The task force produced general statements that should be con-
sidered when interpreting the PTC. These principles cover the
imaging needs of inflammatory arthritis is children and assume
that other important differentials such as infection have been
ruled out.
▸ ‘JIA’ is an umbrella term for all forms of inflammatory arth-
ritis that begins before the age of 16 years, persists for more
than 6 weeks and is of unknown origin. This heterogeneous
group of diseases is currently classified according to the
International League of Associations for Rheumatology clas-
sification.6 There is a lack of information on imaging related
to JIA categories at present.
▸ There is a paucity of data on the joint-specific imaging fea-
tures present during growth and skeletal development in
healthy children. Understanding normative data is essential
for interpretation of imaging abnormalities. For example,
some physiological features of recently ossified bones can be
misinterpreted as cortical erosions, cartilage thickness may
vary with skeletal maturation and vascularity of epiphyses
will change with ageing.
▸ Joint inflammation at certain developmental time points may
cause specific structural changes, further challenging imaging
assessment.
▸ The appropriateness and feasibility of different imaging
modalities differs with age, related to radiation exposure and
requirement for sedation. Every effort should be made to
avoid unnecessary radiation exposure. However, there is a
long established experience with the use of CR to demon-
strate damage.
▸ Patient experience with different imaging modalities is
affected by their age and development. It is important to
provide a ‘child friendly’ environment.
Points to consider
Making a diagnosis of JIA
PTC 1: US and MRI are superior to clinical examination in the
evaluation of joint inflammation; these techniques should be
considered for more accurate detection of inflammation, in diag-
nosis and assessing extent of joint involvement.
Sixty-five studies compared clinical examination with imaging
in the detection of inflammation in various joints, 40 with US,
27 with MRI, 5 with CR and 1 with positron emission tomog-
raphy (table 2). The data is represented according to detection
rates; for example, how many times more (>one fold) or less
(<one fold) does imaging detect inflammation over clinical
examination; this has the potential to increase false positive
results. In general, US and MRI were able to detect joint inflam-
mation more frequently than clinical examination; for example






Level of agreement, mean
NRS 0–10 (range)
1 US and MRI are superior to clinical examination in the evaluation of joint inflammation; these
techniques should be considered for more accurate detection of inflammation, in diagnosis
and assessing extent of joint involvement.
3b C 9.07 (6–10)
2 When there is clinical diagnostic doubt, CR, US or MRI can be used to improve the certainty
of a diagnosis of JIA above clinical features alone.
3b C 9.43 (9–10)
3 If detection of structural abnormalities or damage is required, CR can be used. However MRI
or US may be used to detect damage at an earlier time point than CR.
3b C 8.71 (5–10)
4 In JIA imaging may be of particular benefit over routine clinical evaluation when assessing
certain joints, particularly the use of MRI in detecting inflammation of the TMJ and axial
involvement.
3b C 9.64 (8–10)
5 Imaging in JIA may be considered for use as a prognostic indicator. Damage on CR can be
used for the prediction of further joint damage. Persistent inflammation on US or MRI may be
predictive of subsequent joint damage.
4 C 9.07 (5–10)
6 In JIA, US and MRI can be useful in monitoring disease activity given their sensitivity over
clinical examination and good responsiveness. MRI should be considered for monitoring axial
disease and TMJ.
3b C 9.07 (7–10)
7 The periodic evaluation of joint damage should be considered. The imaging modality used
may be joint dependent.
3b C 8.29 (5–10)
8 US can be used for accurate placement of intra-articular injections. 3b C 9.64 (8–10)
9 US and MRI can detect inflammation when clinically inactive disease is present; this may have
implications for monitoring.
3b C 8.86 (5–10)
The level of evidence and grade of recommendation are based on the Oxford Centre for Evidence-Based Medicine system.5
Level of evidence scale, 1a–5; grade of recommendation scale; A–D. NRS, numerical rating scale (0–10; 0=do not agree at all, 10=fully agree).
CR, conventional radiography; JIA, juvenile idiopathic arthritis; TMJ, temporomandibular joint; US, ultrasound.
Colebatch-Bourn AN, et al. Ann Rheum Dis 2015;74:1946–1957. doi:10.1136/annrheumdis-2015-207892 1947
Recommendation
group.bmj.com on November 29, 2016 - Published by http://ard.bmj.com/Downloaded from 
Table 2 Point to consider 1: Summary of included studies comparing imaging with CE in the detection of joint inflammation
Ultrasound MRI CR
US knees vs CE
13 studies13 14 33 34 38 76–83
MRI knees vs CE
studies13–15 36 72 84–87
CR knees vs CE
3 studies13 15 85








Synovitis/effusion (12 studies)13 14 34 38 76–83 1.19-fold (0.14–3.67-fold) Synovitis vs clinical swelling (3
studies)14 85 86
1.02-fold (0.96–1.12-fold) Joint distension vs swelling (3
studies)13 15 85
0.69-fold (0.45–1.0-fold)
Effusion vs swelling (5 studies)13–15 36 85 1.07-fold (0.75–1.33-fold)
Effusion (1 study)33 Agreement k=0.54
CE missed a significant no. of
effusions
Effusion vs pain (1 study)13 1.45-fold (1.33–1.57-fold)
PD vascularity (2 studies)38 82 1.63-fold (0.96–2.71-fold) Synovial volume vs CRP (1 study)87 r=0.51–0.80
p=0.000–0.036
Joint distension vs pain (1 study)13 1.57-fold
Synovial hypertrophy vs pain (1 study)84 r=0.68–0.74
US hip vs CE
5 studies13 16 78 88 89
MRI hip vs CE
5 studies13 15 90–92
CR hip vs CE
1 study15
Synovitis/effusion (5 studies)13 16 78 88 89 0.85-fold (0.13–1.39-fold) MRI inflammation (4 studies)13 15 90 91 0.88-fold (0.50–1.78-fold) Joint distension vs clinical effusion (1 study)15 0.80-fold
Synovitis/effusion vs LOM (1 study)89 Association
p=0.006
Synovitis/effusion vs pain (1 study)89 Association
p=0.103
Synovial enhancement (1 study)91 0.94-fold
US hands/wrists vs CE
4 studies38 40 93 94
MRI hands/wrists vs CE
2 studies19 95








Joint distension vs clinical effusion
(1 study)93
0.63-fold
PD vascularity (2 studies)38 40 0.96-fold
GS synovitis had weaker correlation with clinical disease
activity than PD




Significant association with clinical disease activity Synovitis score vs wrist swelling score
(1 study)19
MRI score significantly higher with higher
swelling score
p<0.00001
US ankles/feet vs CE
5 studies38 79 96–98
MRI ankles/feet vs CE
1 study99
Synovitis/effusion (3 studies)38 79 96 0.97-fold (0.86-1.04-fold) Tibiotalar synovitis (1 study)99 1.00-fold
PD vascularity (1 study)38 0.57-fold Subtalar synovitis (1 study)99 3.33-fold
US TMJ vs CE3 studies25 100 101
MRI TMJ vs CE
8 studies25 41 42 102–106
Synovitis/effusion (2 studies)25 100 11.7-fold (0.35–23.0-fold) Synovitis (6 studies)25 41 42 104–106 2.46-fold (1.10–5.91-fold)
Synovitis vs reduced MIO (4 studies)25 102 103 105 Significantly correlated
Reduced MIO best predictor of active MRI changes





























US enthesitis vs CE
3 studies107–109
MRI enthesitis vs CE
1 study110
US enthesitis vs CE
3 studies107–109
MRI enthesitis vs CE
1 study110
Enthesitis (3 studies)107–109 0.79-fold (0.53–1.09-fold) Enthesitis (1 study)110 0.50-fold
US VARIOUS MULTIPLE JOINTS vs CE
9 studies48 50 64 111–117
MRI VARIOUS MULTIPLE JOINTS vs CE
1 study110
CR VARIOUS MULTIPLE JOINTS vs CE
1 study118
Synovitis/effusion (6 studies)48 111–114 116 1.85-fold (1.00–3.33-fold) Synovitis/effusion
(1 study)110
1.08-fold Soft tissue swelling vs clinical swelling
(1 study)118
1.05-fold





Association synovitis vs CE (2 studies)50 117 Swelling: r=0.50
LOM: r=0.40
Pain: r=0.21
CE missed inflammation in 25.2%
joints
MRI cervical spine vs CE
1 study20
Synovitis/SH (1 study)20 4.25-fold
MRI SIJ vs CE
2 studies23 119
Sacroiliitis (2 studies)23 119 0.93-fold
CE was normal in 22.9% patients with MRI
sacroiliitis



























the mean (range) detection rate for synovitis and effusion at the
knee was 1.19-fold (0.14–3.67-fold) for US and 1.02-fold
(0.96–1.12-fold) for MRI knee synovitis.
PTC 2: When there is clinical diagnostic doubt, CR, US or
MRI can be used to improve the certainty of a diagnosis of JIA
above clinical features alone.
The diagnosis of JIA is mainly based on clinical features and
the exclusion of other causes of chronic arthritis. However this
point illustrates the role of imaging when there is diagnostic
doubt; no specific imaging signatures for JIA have been
described yet, but imaging is helpful to narrow the differential
diagnosis. Four studies compared imaging features in suspected/
proven JIA with either controls or other disease entities, includ-
ing infectious arthritis, acute lymphoblastic leukaemia and
haemophilia.7–10 US detected more joint inflammation than clin-
ical examination; two studies specifically described US improv-
ing the diagnostic certainty in subjects with suspected JIA.11 12
Detecting damage
PTC 3: If detection of structural abnormalities or damage is
required, CR can be used. However MRI or US may be used to
detect damage at an earlier time point than CR.
Thirty-seven studies compared joint damage (erosions, joint
space narrowing ( JSN), deformity) detected by imaging with
clinical findings suggestive of underlying damage, such as ten-
derness, limitation of movement and crepitus. In general, all
imaging modalities appeared to detect less joint damage than
suggested by clinical examination; for example the mean (range)
detection rate for cartilage loss at the knee was 0.32-fold for
US, 0.63-fold (0.20–1.0-fold) for MRI and 0.46-fold (0.23–
0.71-fold) for CR when compared with pain.13–15 This reflects
the poor sensitivity of pain as an indicator of underlying
damage.
When the imaging modalities are directly compared MRI and
US detected more joint damage than CR, particularly at the hip
(MRI vs CR detection rate, mean (range) 1.54-fold (1.08–
2.0-fold); US vs CR detection rate, mean 2.29-fold), and at the
wrist (MRI vs CR detection rate, 1.36-fold (1.0–2.0-fold)).13 15–19
Imaging specific joints
PTC 4: In JIA imaging may be of particular benefit over routine
clinical evaluation when assessing certain joints, particularly the
use of MRI in detecting inflammation of the temporomandibu-
lar joint (TMJ) and axial involvement.
Cervical spine MRI appears better at detecting inflammation
than clinical examination; one study showed 20% of patients
had pain and/or limitation of movement whereas 85% had MRI
inflammatory changes suggesting that cervical spine involvement
in JIA is often clinically silent.20 MRI and CR have shown
better detection rates than clinical examination for structural
changes in the cervical spine (4.5-fold and mean, range 2.29
(1.58–3.0-fold)), respectively.21 22 Abnormal sacroiliac joint
(SIJ) imaging is also demonstrated despite a high rate of normal
examination; for example, normal SIJ examination in 42.9%
and 22.9%, in patients with CR and MRI sacroiliitis,
respectively.23 24
Muller et al25 compared TMJ clinical examination and US
with MRI changes, and found that examination correctly identi-
fied 58% patients with active MRI TMJ arthritis compared with
33% for US, and missed inflammation in 42% and 67%,
respectively. They described reduced maximal incisal opening to
be the best predictor of active MRI changes.26 Full data compar-
ing the various imaging modalities with clinical examination of
the TMJ is given in the online supplementary text S9.
Prognosis
PTC 5: Imaging in JIA may be considered for use as a prognos-
tic indicator. Damage on CR can be used for the prediction of
further joint damage. Persistent inflammation on US or MRI
may be predictive of subsequent joint damage.
Thirteen observational studies examined the relationship
between baseline imaging and subsequent radiographic and clin-
ical outcome; 11 with CR and 2 with MRI at baseline. The
statement on US inflammation is therefore based on expert
opinion; the findings are given in full in table 3. In general, CR
damage in the 1st year has a moderate correlation with func-
tional deterioration according to Steinbocker class, Childhood
Health Assessment Questionnaire and physician/parent disability
scores at 5 years, as well as with CR progression at 5 years.27–29
A baseline CR wrist adapted Sharp van der Heijde score >1 was
shown to be predictive of CR progression at 5 years (OR, 8.2),
and patients with erosions and/or JSN in the first 6 months of
the study spent more time with clinically active disease and were
less likely to achieve clinical remission on medication.30 31 Just
one study described the correlation of baseline MRI wrist syn-
ovial volume with MRI erosive progression at 1 year; this found
a moderate correlation, and all patients with high synovial
volume at baseline had erosive progression.32
Monitoring inflammation
PTC 6: In JIA, US and MRI can be useful in monitoring disease
activity given their sensitivity over clinical examination and
good responsiveness. MRI should be considered for monitoring
axial disease and TMJ.
Data comparing imaging with clinical examination in detect-
ing joint inflammation is discussed in PTC 1, and specific infor-
mation on imaging the TMJ and for axial involvement is
summarised in PTC 4. This section will consider the compari-
son of the ability of imaging to detect inflammation, responsive-
ness of imaging to change in inflammation, and which joints
should be assessed.
Comparison of the ability of imaging to detect inflammation
Several studies compared US with MRI in the detection of
inflammation, particularly at the knee.13 14 33 34 These studies
have shown MRI to be better in detecting knee inflammation
than US (mean detection rate 1.20-fold, range 0.63–1.56-fold)
and in particular MRI was better than US in differentiating
pannus from effusion.13 Knee MRI with contrast enhancement
was more reliable at localising and differentiating synovial
hypertrophy from synovial fluid particularly when there was
<5 mm of synovial hypertrophy, but the addition of contrast
did not provide additional information in the assessment of
inflammatory bone marrow lesions.35–37 Comparison of power
Doppler with grey-scale wrist US has resulted in conflicting
results, whereas the use of contrast significantly increased knee
US synovial pixel intensity in those with symptomatic disease
(p=0.004) and asymptomatic disease (p=0.0001), but not in
those in clinical remission.38–40
Studies comparing TMJ US with MRI have shown a poor cor-
relation between these modalities, with US missing 67–75% of
TMJ MRI inflammation.25 41 The use of MRI contrast enhance-
ment improved the detection of MRI TMJ inflammation from
35.7% to 86.7%.42 One study examined the CR findings in
patients with TMJ MRI synovitis and found significant correl-
ation with abnormal condyle morphology and accentuated ante-
gonial notching on CR, and joints with both of these changes
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Table 3 Point to consider 5: Summary of included studies describing the prognostic value of the imaging modalities
Reference No. of subjects Duration of follow-up (months) Radiological or clinical assessment Outcome assessed Correlation
Baseline CR predictive factors
Susic et al120 87 48 Wrist involvement CHAQ-DI Significant correlation
p<0.01




Ravelli et al29 96 min. 60 CR wrist changes at: baseline in
1st year in 1st 5 years
No. of joints with LOM Baseline: low r=0.16
1st year: low r=0.35
1st 5 years: moderate r=0.59
JADI-A Baseline: low r=0.21
1st year: moderate r=0.53
1st 5 years: moderate r=0.60
Steinbocker functional class Baseline: low r=0.21
1st year: moderate r=0.48
1st 5 years: moderate r=0.55
CR progression at 5 years Baseline: low r=0.38
1st year: moderate r=0.61
1st 5 years: high r=0.89
Pederzoli et al30 130 min. 60 CR wrist a SH score > 1 CR progression at 5 years Significant predictor
OR 8.2
Magni-Manzoni et al28 94 54 Baseline Poznanski score CR progression in 1st yr












Bertamino et al27 148 max. 132 CR hip progression in 1st year CHAQ r=0.24, p=0.1
SJC r=0.03, p=0.86
TJC r=0.06, p=0.65
No. of joints with LOM r=0.46, p=0.0005
Steinbocker functional class r=0.50, p=0.005
JADI-A r=0.45, p=0.01
Physician disability score r=0.40, p=0.05
Parent disability score r=0.53, p=0.007
Oen et al121 136 min. 60 Early (<2 years) erosions/JSN CHAQ No correlation
Selvaag et al122 197 36 Baseline swelling/osteopenia CR erosive progression OR 7.95, p<0.001





























Reference No. of subjects Duration of follow-up (months) Radiological or clinical assessment Outcome assessed Correlation
Ringold et al31 104 29.9 Early (<6 months) erosions/JSN vs normal Time with active disease
CRM
More time with active disease
p<0.001
Less chance of CRM, RR=0.34, p<0.001
RF +ve vs −ve More time with active disease
p=0.07
Oen et al54 88 Early (<2 years)
Late (1–20.8 years)
Late vs early JSN CHAQ Significant correlation
Explains 17.7% of variation in CHAQ
Joint pain Explains 32.4% of variation in CHAQ
Habib et al123 68 – ACPA CR erosions Significant correlation
p=0.004
Arvidsson et al124 103 324 Baseline/early TMJ involvement Micrognathia 66.7% patients with micrognathia had baseline TMJ
involvement; 33.3% had CR TMJ involvement within
2 years
Baseline MRI predictive factors
Malattia et al32 58 12 Baseline wrist synovial volume MRI erosive progression Correlation r=0.42
p<0.02
All patients with high synovial volume had erosive
progression
Baseline CRP Correlation r=0.40
p<0.02
Gardner-Medwin et al125 10 12 Baseline synovial hypertrophy in a clinically normal joint Disease extension from monoarthritis 100% patients developed clinical arthritis in other
joints
ACPA, anticyclic citrullinated peptide antibody; aSH, adapted Sharp van der Heijde score; CHAQ-DI, Childhood Health Assessment Questionnaire disability index; CR, conventional radiography; CRM, clinical remission on medication; CRP, C reactive protein;



























on CR were 7.5 times more likely to have MRI synovitis (OR
7.55, 95% CI 1.66 to 34.4, p=0.009).43
Responsiveness of imaging to change in inflammation
US and MRI have been shown to have good responsiveness to
change in inflammation, as measured by standardised response
means (SRM, ≥0.20 small change, ≥0.50 moderate, ≥0.80
good). The mean (range) SRM for MRI wrist synovitis was
good at 1.27 (0.51 to 1.69) and demonstrated ability to discrim-
inate between different levels of clinical responder categories,
whereas the SRM for MRI wrist bone marrow oedema was
small at 0.22.19 32 44 Similar levels of SRM have been described
for MRI knee synovial hypertrophy (0.68–0.70) and bone
marrow oedema (0.15).45 46 A comparison of MRI wrist syno-
vitis score with US showed higher MRI responsiveness (1.61)
when compared with US grey-scale (0.87) and US power
Doppler (0.71).47
Which joints to assess
Studies describing the frequency of US joint inflammation in JIA
have shown these changes to be most common in the knee
(∼30%) and wrist (∼20%), then ankle, proximal interphalangeal
joint and metatarsophalangeal joint (∼10% each).48 49 US
power Doppler activity was most common in the wrist
(∼35%).48 49 One study examined the frequency of US periph-
eral synovitis and found changes more commonly in the meta-
tarsophalangeal joint (61.9%) than in the metacarpophalangeal
joint (39%), with the first metatarsophalangeal joint and second
metacarpophalangeal joint most frequently affected (20% and
13%, respectively).50
Monitoring damage
PTC 7: The periodic evaluation of joint damage should be con-
sidered. The imaging modality used may be joint dependent.
As for PTC 6, this section will consider the comparison of
the ability of imaging to detect damage, responsiveness of
imaging to change in damage, and which joints should be
assessed. Data comparing imaging with clinical examination in
detecting joint damage and comparing CR with MRI and US in
detecting damage is discussed in part in PTC 3.
Comparison of the ability of imaging to detect damage
El-Miedany et al14 examined the role of MRI, US and CR in
the detection of knee JSN and described a 3.14-fold detection
rate of MRI compared with US, 4.40-fold for MRI compared
with CR and 1.4-fold for US compared with CR. The addition
of contrast to MRI enhanced the appreciation of depth of cartil-
age involvement by 1.42-fold. Data describing the detection of
wrist erosive changes have shown a detection rate for MRI com-
pared with US of 1.92-fold, MRI compared with CR of
1.36-fold and US compared with CR of 1.0-fold.17–19 40
In terms of detecting damage of the TMJ, Muller et al25
showed that MRI condylar damage was detected in 25% of
their cohort, whereas US detected only 17% (1.47-fold). Weiss
et al41 also described a poor correlation between these modal-
ities, with only 50% agreement (detection rate 2.44-fold).
Responsiveness of imaging to change in damage
Several studies examined the responsiveness of imaging to
detect change in damage at the wrist, particularly with CR and
MRI. The rate of change in CR score (Larsen, Sharp, Poznanski)
appears to be greatest in the 1st year, which is mainly due to
progression in JSN.28 51 This seems to slow after the 1st year,
whereas the rate of erosive change is steady from baseline to
year 3; the rate of progression overall slows after 3rd third year.
In general, the rate of JSN exceeds that of erosions and total
score.29 When compared with CR, Malattia et al44 described
the relative efficacy of MRI compared with CR erosion score to
be <1 at year 1; that is, MRI was less responsive than CR in
detecting erosive progression; the fact that cartilage assessment
was not included in the MRI scoring systems might explain this
result. A study of TMJ condylar changes showed that MRI iden-
tified significantly more changes than CR (p≤0.003), and MRI
was superior to CR in following condylar changes over time:
MRI condylar changes at baseline were found in 58.6% com-
pared with 80% at year 2; CR condylar changes were stable at
baseline and year 2 at 30%.52
Which joints to assess
Studies describing the distribution of CR changes in ‘early’
(within 2 years of disease onset) and ‘late’ (up to 20.8 years of
follow-up) disease have shown JSN to be most common in early
disease in the wrist (20%), hips (16%), cervical spine (5%),
ankles (4%) and knees (3%) compared with 34%, 25%, 38%,
15% and 6%, respectively in late disease.53 54 Rostom et al55
observed CR hip disease to start after 4 years of disease,
whereas 80% had developed hip disease at 6 years, and 100%
after 14 years. Other studies describing radiological features of
JIA found most CR changes in the hands (57%), knees (47%),
ankles (27%) and feet (36%), with erosions mainly in hands
(18%) and feet (25%).56 The hands and feet were the area most
likely to show CR damage progression at 6 months and
5 years.57 58
Guided treatment
PTC 8: US can be used for accurate placement of intra-articular
injections.
Studies summarising the role of imaging for guiding
intra-articular steroid injections are given in online supplemen-
tary text S10, along with additional data on the use of imaging
to assess and monitor efficacy of steroid injections. All studies
used triamcinolone injections; doses and preparations varied
according to the age of the patient and the joint being injected.
Young et al59 used US to assess the accuracy of needle placement
for steroid injections at various sites ( joints and tendon
sheaths), and described that US allowed accurate visualisation of
the injection point in all 1444 injections. A study by Parra
et al60 used CT to establish if US-guided TMJ injections had
been accurately placed; needle placement was shown to be
acceptable in 91% (75% required no needle adjustment, 16%
required minor adjustment) and unacceptable in 9% where the
needle required major readjustment. A study of the efficacy of
TMJ injections used MRI to assess needle placement accuracy
according to the location (intra-articular or extra-articular) of
the injected material on MRI acquired after injection; MRI
confirmed that 65% of injections were accurately placed.61
A similar study using postinjection MRI of the SIJ described
technical success in 100%.62
Remission
PTC 9: US and MRI can detect inflammation when clinically
inactive disease is present; this may have implications for
monitoring.
Several studies addressed the discrepancy between clinical
remission and inflammation seen on US and MRI; these are
summarised in the online supplementary text S11. Evidence of
ongoing US synovitis has been described in 56.1–94.1% of
patients with clinically inactive joints, and 32% of patients with
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inactive disease showed US signs of synovial hypertrophy, effu-
sion and power Doppler activity.63–65 In clinical remission, US
grey-scale synovitis was seen in up to 84.1% of joints, and
power Doppler activity in up to 48.6% of joints, with a non-
significant trend to more US inflammation in clinical remission
on medication compared with clinical remission off medica-
tion.39 66–71 MRI knee inflammation has been demonstrated in
up to 50% of patients in clinical remission and bone marrow
oedema in 33.3% patients with clinically inactive joints.72–74
Recent pilot studies have demonstrated that patients with sub-
clinical US or MRI inflammation are more likely to develop
active disease and disease progression, even within 6 months of
follow-up.64 70 74 75
Research agenda
The group formulated a research agenda based on areas identi-
fied with a lack of currently available evidence, shown in box 1.
DISCUSSION
These EULAR-PReS considerations for imaging provide import-
ant and novel advice for JIA in clinical practice. There is still sig-
nificant research needed in this field, in particular consensus on
understanding normative data to allow the interpretation of
imaging abnormalities, agreement on appropriate MRI proto-
cols and definitions of bone marrow oedema, synovitis and ero-
sions, and suitability of the imaging modalities for detecting
changes at specific joints. Our data is limited by the lack of spe-
cific information for each JIA disease subtype; this is reflected in
the research agenda.
There are significant conceptual differences between imaging
in adult and paediatric conditions, and consideration must be
given to the appropriateness and feasibility of different imaging
modalities which differs with age and developmental stage, as
well as to economic issues such as the cost-effectiveness of the
intervention. Repeated unnecessary exposure to radiation from
imaging should also be considered. We appreciate that access to
individual imaging modalities may be insufficient to allow full
implementation of these PTC; however most of the points
include the use of US which is generally readily available. An
economic evaluation was not included in the process as the
primary aim was to discuss the clinical implications of imaging;
overall the cost of implementing the PTC should be low.
After dissemination of the PTC by means of publication and
presentation at European meetings, we would propose to
perform a survey of awareness and their use, for example:
▸ Do you have access to musculoskeletal US and MRI
routinely?
▸ Are you aware of and implementing the EULAR-PReS JIA
imaging PTC?
▸ Have the PTC changed your clinical practice?
The task force agreed that it was not appropriate to create
audit or implementation tools as the strength of data was only
sufficient to develop PTC rather than recommendations.
In summary, we have developed nine PTC on the role of
imaging in various clinical aspects in JIA. We would recommend
that a similar rigorous process is followed to reassess the avail-
able data after an interval of 5 years.
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Box 1 Research agenda
1. What are the age-specific changes in imaging, including
age-specific intervals for imaging, development of an atlas
of age-specific normal images and a registry as mechanism
for pooling of data
2. Development of validated scoring systems including
pathology definition (eg, differentiating reversible structural
abnormalities from damage), imaging acquisition protocols
and quantification
3. What are the imaging characteristics of the subtypes of JIA,
and which target sites should be imaged?
4. What is the clinical significance of imaging-detected
subclinical disease in diagnosis, monitoring and remission?
5. What is the usefulness of imaging-guided injection over
non-imaging guided injection?
6. What is the prognostic value of specific imaging features, for
example BM oedema?
7. Can imaging be used to assess and monitor disease
progression and response to treatment including the
development of structural damage?
8. What is the feasibility, cost and appropriate training for
using US and MRI in JIA in clinical practice?
JIA, juvenile idiopathic arthritis; BM, bone marrow; US,
ultrasound.
1954 Colebatch-Bourn AN, et al. Ann Rheum Dis 2015;74:1946–1957. doi:10.1136/annrheumdis-2015-207892
Recommendation
group.bmj.com on November 29, 2016 - Published by http://ard.bmj.com/Downloaded from 
REFERENCES
1 Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet 2011;377:2138–49.
2 van der Heijde D, Aletaha D, Carmona L, et al. 2014 Update of the EULAR
standardised operating procedures for EULAR-endorsed recommendations. Ann
Rheum Dis 2015;74:8–13.
3 Brouwers MC, Kho ME, Browman GP, et al. AGREE II: advancing guideline
development, reporting and evaluation in health care. Can Med Assoc J
2010;182:E839–42.
4 Whiting PF, Rutjes AWS, Westwood ME, et al. QUADAS-2: a revised tool for the
quality assessment of diagnostic accuracy studies. Ann Intern Med
2011;155:529–36.
5 Oxford Centre for Evidence Based Medicine—Levels of Evidence (updated March
2009). http://www.cebm.net/index.aspx?o=1025 (accessed 30 Oct 2014).
6 Petty RE, Southwood TR, Manners P, et al. International League of Associations
for Rheumatology classification of juvenile idiopathic arthritis: second revision,
Edmonton, 2001. J Rheumatol 2004;31:390–2.
7 Chlosta EM, Kuhns LR, Holt JF. The “patellar ratio” in hemophilia and juvenile
rheumatoid arthritis. Radiology 1975;116:137–8.
8 Kirkhus E, Flato B, Riise O, et al. Differences in MRI findings between subgroups
of recent-onset childhood arthritis. Pediatr Radiol 2011;41:432–40.
9 Tafaghodi F, Aghighi Y, Rokni Yazdi H, et al. Predictive plain X-ray findings in
distinguishing early stage acute lymphoblastic leukemia from juvenile idiopathic
arthritis. Clin Rheumatol 2009;28:1253–8.
10 Uhl M, Krauss M, Kern S, et al. The knee joint in early juvenile idiopathic arthritis.
An ROC study for evaluating the diagnostic accuracy of contrast-enhanced MR
imaging. Acta Radiol 2001;42:6–9.
11 Filippou G, Cantarini L, Bertoldi I, et al. Ultrasonography vs. clinical examination
in children with suspected arthritis. Does it make sense to use poliarticular
ultrasonographic screening? Clin Exp Rheumatol 2011;29:345–50.
12 Ramos PC, Calvo C, Diaz-Delgado R. The role of musculoskeletal ultrasound in
children with pain in the upper limbs [abstract]. Clin Exp Rheumatol 2011;29:410.
13 Eich GF, Halle F, Hodler J, et al. Juvenile chronic arthritis: imaging of the knees
and hips before and after intraarticular steroid injection. Pediatr Radiol
1994;24:558–63.
14 El-Miedany YM, Housny IH, Mansour HM, et al. Ultrasound versus MRI in the
evaluation of juvenile idiopathic arthritis of the knee. Joint Bone Spine
2001;68:222–30.
15 Senac MO Jr, Deutsch D, Bernstein BH, et al. MR imaging in juvenile rheumatoid
arthritis. AJR Am J Roentgenol 1988;150:873–8.
16 Fedrizzi MS, Ronchezel MV, Hilario MO, et al. Ultrasonography in the early
diagnosis of hip joint involvement in juvenile rheumatoid arthritis. J Rheumatol
1997;24:1820–5.
17 Boavida P, Hargunani R, Owens CM, et al. Magnetic resonance imaging and
radiographic assessment of carpal depressions in children with juvenile idiopathic
arthritis: normal variants or erosions? J Rheumatol 2012;39:645–50.
18 Malattia C, Damasio MB, Magnaguagno F, et al. Magnetic resonance imaging,
ultrasonography, and conventional radiography in the assessment of bone erosions
in juvenile idiopathic arthritis. Arthritis Rheum 2008;59:1764–72.
19 Malattia C, Damasio MB, Pistorio A, et al. Development and preliminary validation
of a paediatric-targeted MRI scoring system for the assessment of disease activity
and damage in juvenile idiopathic arthritis. Ann Rheum Dis 2011;70:440–6.
20 Tzaribachev N, Tzaribachev C, Koos B. High prevalence of cervical spine and
temporomandibular joint involvement in patients with juvenile idiopathic arthritis
[abstract]. Arthritis Rheum 2012;64(Suppl 10):2026.
21 Oren B, Oren H, Osma E, et al. Juvenile rheumatoid arthritis: cervical spine
involvement and MRI in early diagnosis. Turk J Pediatr 1996;38:189–94.
22 Elhai M, Wipff J, Bazeli R, et al. Radiological cervical spine involvement in young
adults with polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford)
2013;52:267–75.
23 Lin C, Milojevic D. MRI Findings In Juvenile Spondyloarthopathy and effects of
treatment on subsequent MRI [abstract]. Arthritis Rheum 2013;65(Suppl 10):288.
24 Burgos-Vargas R, Vazquez-Mellado J, Cassis N, et al. Genuine ankylosing
spondylitis in children: a case-control study of patients with early definite disease
according to adult onset criteria. J Rheumatol 1996;23:2140–7.
25 Muller L, Kellenberger CJ, Cannizzaro E, et al. Early diagnosis of
temporomandibular joint involvement in juvenile idiopathic arthritis: a pilot study
comparing clinical examination and ultrasound to magnetic resonance imaging.
Rheumatology (Oxford) 2009;48:680–5.
26 Stabrun AE, Larheim TA, Hoyeraal HM. Temporomandibular joint involvement in
juvenile rheumatoid arthritis. Clinical diagnostic criteria. Scand J Rheumatol
1989;18:197–204.
27 Bertamino M, Rossi F, Pistorio A, et al. Development and initial validation of a
radiographic scoring system for the hip in juvenile idiopathic arthritis. J Rheumatol
2010;37:432–9.
28 Magni-Manzoni S, Rossi F, Pistorio A, et al. Prognostic factors for radiographic
progression, radiographic damage, and disability in juvenile idiopathic arthritis.
Arthritis Rheum 2003;48:3509–17.
29 Ravelli A, Ioseliani M, Norambuena X, et al. Adapted versions of the Sharp/van
der Heijde score are reliable and valid for assessment of radiographic progression
in juvenile idiopathic arthritis. Arthritis Rheum 2007;56:3087–95.
30 Pederzoli S, Tsitsami E, Consolaro A, et al. Early functional impairment and
structural changes predict long-term damage in children with polyarticular juvenile
idiopathic arthritis [abstract]. Clin Exp Rheumatol 2011;29:456.
31 Ringold S, Seidel KD, Koepsell TD, et al. Inactive disease in polyarticular juvenile
idiopathic arthritis: current patterns and associations. Rheumatology (Oxford)
2009;48:972–7.
32 Malattia C, Damasio MB, Basso C, et al. Novel automated system for magnetic
resonance imaging quantification of the inflamed synovial membrane volume in
patients with juvenile idiopathic arthritis. Arthritis Care Res 2012;64:1657–64.
33 Pascoli L, Napier NJ, Wray M, et al. A prospective comparative study of three
methods of assessment of the knee joint in juvenile idiopathic arthritis: clinical
examination, ultrasound and MRI (a newly developed knee MRI scoring system)
[abstract]. Ann Rheum Dis 2012;71(Suppl 3):263.
34 Pascoli L, Napier NJ, Wray M, et al. Knee joint in JIA: a prospective evaluation of
clinical examination, ultrasound and MRI assessment. A newly developed knee
MRI scoring system in JIA [abstract]. Rheumatology (Oxford) 2010;49(Suppl 1):
i86–7.
35 Hemke R, Kuijpers TW, van den Berg JM, et al. The diagnostic accuracy of
unenhanced MRI in the assessment of joint abnormalities in juvenile idiopathic
arthritis. Eur Radiol 2013;23:1998–2004.
36 Herve-Somma CM, Sebag GH, Prieur AM, et al. Juvenile rheumatoid arthritis of
the knee: MR evaluation with Gd-DOTA. Radiology 1992;182:93–8.
37 Johnson K, Wittkop B, Haigh F, et al. The early magnetic resonance imaging
features of the knee in juvenile idiopathic arthritis. Clin Radiol 2002;57:466–71.
38 Collado P, Naredo E, Calvo C, et al. Reduced joint assessment vs comprehensive
assessment for ultrasound detection of synovitis in juvenile idiopathic arthritis.
Rheumatology (Oxford) 2013;52:1477–84.
39 Doria AS, Kiss MH, Lotito AP, et al. Juvenile rheumatoid arthritis of the knee:
evaluation with contrast-enhanced color Doppler ultrasound. Pediatr Radiol
2001;31:524–31.
40 Malattia C, Damasio MB, Pistorio A, et al. Development and preliminary validation
of a wrist ultrasound scoring system for the assessment of disease activity and
damage in JIA: A comparison with MRI and clinical examination [abstract]. Clin
Exp Rheumatol 2011;29:385.
41 Weiss PF, Arabshahi B, Johnson A, et al. High prevalence of temporomandibular
joint arthritis at disease onset in children with juvenile idiopathic arthritis, as
detected by magnetic resonance imaging but not by ultrasound. Arthritis Rheum
2008;58:1189–96.
42 Kuseler A, Pedersen TK, Herlin T, et al. Contrast enhanced magnetic resonance
imaging as a method to diagnose early inflammatory changes in the
temporomandibular joint in children with juvenile chronic arthritis. J Rheumatol
1998;25:1406–12.
43 Abramowicz S, Simon L, Susarla HK, et al. Are panoramic radiographs predictive of
temporomandibular joint synovitis in children with juvenile idiopathic arthritis?
[abstract]. J Oral Maxillofac Surg 2013;71(Suppl 1):e93.
44 Malattia C, Consolaro A, Pederzoli S, et al. MRI versus conventional measures of
disease activity and structural damage in evaluating treatment efficacy in juvenile
idiopathic arthritis. Ann Rheum Dis 2013;72:363–8.
45 Hemke R, van Rossum MA, van Veenendaal M, et al. Reliability and
responsiveness of the Juvenile Arthritis MRI Scoring ( JAMRIS) system for the knee.
Eur Radiol 2013;23:1075–83.
46 Hemke R, van Veenendaal M, van den Berg JM, et al. One-year followup study on
clinical findings and changes in magnetic resonance imaging-based disease activity
scores in juvenile idiopathic arthritis. J Rheumatol 2014;41:119–27.
47 Malattia C, Consolaro A, Pederzoli S, et al. MRI and ultrasound versus
conventional measures of disease activity and structural damage in evaluating
treatment efficacy in JIA. Do these imaging techniques have an additional value?
[abstract]. Pediatr Rheumatol 2011;9(Suppl 1):O12.
48 Magni-Manzoni S, Epis O, Ravelli A, et al. Comparison of clinical versus
ultrasound-determined synovitis in juvenile idiopathic arthritis. Arthritis Rheum
2009;61:1497–504.
49 Magni-Manzoni S, Scire CA, Ravelli A, et al. Ultrasound-detected synovial
abnormalities are frequent in clinically inactive juvenile idiopathic arthritis, but do
not predict a flare of synovitis. Ann Rheum Dis 2013;72:223–8.
50 Breton S, Jousse-Joulin S, Cangemi C, et al. Comparison of clinical and
ultrasonographic evaluations for peripheral synovitis in juvenile idiopathic arthritis.
Semin Arthritis Rheum 2011;41:272–8.
51 Rossi F, Di Dia F, Galipo O, et al. Use of the Sharp and Larsen scoring methods in
the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis
Rheum 2006;55:717–23.
52 Pedersen TK, Kuseler A, Gelineck J, et al. A prospective study of magnetic
resonance and radiographic imaging in relation to symptoms and clinical findings
of the temporomandibular joint in children with juvenile idiopathic arthritis. J
Rheumatol 2008;35:1668–75.
Colebatch-Bourn AN, et al. Ann Rheum Dis 2015;74:1946–1957. doi:10.1136/annrheumdis-2015-207892 1955
Recommendation
group.bmj.com on November 29, 2016 - Published by http://ard.bmj.com/Downloaded from 
53 Lang BA, Schneider R, Reilly BJ, et al. Radiologic features of systemic onset
juvenile rheumatoid arthritis. J Rheumatol 1995;22:168–73.
54 Oen K, Reed M, Malleson PN, et al. Radiologic outcome and its relationship to
functional disability in juvenile rheumatoid arthritis. J Rheumatol 2003;30:832–40.
55 Rostom S, Amine B, Bensabbah R, et al. Hip involvement in juvenile idiopathic
arthritis. Clin Rheumatol 2008;27:791–4.
56 van Rossum MA, Zwinderman AH, Boers M, et al. Radiologic features in juvenile
idiopathic arthritis: a first step in the development of a standardized assessment
method. Arthritis Rheum 2003;48:507–15.
57 van Rossum MA, Boers M, Zwinderman AH, et al. Development of a standardized
method of assessment of radiographs and radiographic change in juvenile
idiopathic arthritis: introduction of the Dijkstra composite score. Arthritis Rheum
2005;52:2865–72.
58 Williams RA, Ansell BM. Radiological findings in seropositive juvenile chronic
arthritis ( juvenile rheumatoid arthritis) with particular reference to progression.
Ann Rheum Dis 1985;44:685–93.
59 Young CM, Shiels WE 2nd, Coley BD, et al. Ultrasound-guided corticosteroid
injection therapy for juvenile idiopathic arthritis: 12-year care experience. Pediatr
Radiol 2012;42:1481–9.
60 Parra DA, Chan M, Krishnamurthy G, et al. Use and accuracy of US guidance for
image-guided injections of the temporomandibular joints in children with arthritis.
Pediatr Radiol 2010;40:1498–504.
61 Saurenmann RK, Muller L, Schroeder S, et al. Efficacy of intra-articular steroid
injection into the temporomandibular joint in children with juvenile idiopathic
arthritis [abstract]. Arthritis Rheum 2009;60(Suppl 10):243.
62 Fritz J, Tzaribachev N, Thomas C, et al. Evaluation of MR imaging guided steroid
injection of the sacroiliac joints for the treatment of children with refractory
enthesitis-related arthritis. Eur Radiol 2011;21:1050–7.
63 Donati C, Soldi A, De Lucia O, et al. Comparison of clinical and ultrasonographic
examination of 7200 joints in 100 JIA patients satisfying Wallace criteria of
inactive disease (ID), suggests to add ultrasonography as a new criteria of ID
[abstract]. Ann Rheum Dis 2012;71(Suppl 3):426.
64 Nielsen HE, Strandberg C, Andersen S, et al. Ultrasonographic examination in
juvenile idiopathic arthritis is better than clinical examination for identification of
intraarticular disease. Dan Med J 2013;60:A4669.
65 Halbwachs M, Durand G. Should joint ultrasound contribute to therapeutic
decisions in juvenile idiopathic arthritis? [abstract]. Arthritis Rheum 2012;64(Suppl
10):2023.
66 Collado P, Gamir ML, Merino R, et al. Detection of synovitis in clinically inactive
juvenile idiopathic arthritis patients by ultrasonography with power Doppler
[abstract]. Arthritis Rheum 2012;64(Suppl 10):123.
67 Molina C, Santos C, Modesto C, et al. Subclinical synovitis detected by ultrasound
in patients with oligoarticular JIA in clinical remission [abstract]. Clin Exp
Rheumatol 2011;29:416.
68 Parsa MF, Rullo OJ, Woo JMP, et al. Ultrasound and plasma osteopontin improve
the assessment of remission in oligoarticular juvenile idiopathic arthritis [abstract].
Arthritis Rheum 2011;63(Suppl 10):254.
69 Rebollo-Polo M, Koujok K, Weisser C, et al. Ultrasound findings on patients with
juvenile idiopathic arthritis in clinical remission. Arthritis Care Res
2011;63:1013–19.
70 Silva V, Mitraud S, Furtado R, et al. Preliminary prospective study of
ultrasonography in patients with juvenile idiopathic arthritis in clinical remission:
subclinical synovitis may predict flare? [abstract]. Arthritis Rheum 2013;65(Suppl
10):298.
71 Bugni Miotto e Silva V, de Freitas Tavares da Silva C, de Aguiar Vilela Mitraud S,
et al. Do patients with juvenile idiopathic arthritis in remission exhibit active
synovitis on joint ultrasound? Rheumatol Int 2014;34:937–45.
72 Hemke R, Maas M, Veenendaal M, et al. Contrast-enhanced MRI compared with
the physical examination in the evaluation of disease activity in juvenile idiopathic
arthritis. Eur Radiol 2014;24:327–34.
73 Van Veenendaal M, Hemke R, Bos MI, et al. MRI evaluation of clinical remission
in juvenile idiopathic arthritis [abstract]. Pediatr Rheumatol Online J 2011;9(Suppl
1):P114.
74 Van Veenendaal M, Hemke R, Bos MI, et al. Magnetic resonance imaging in
follow-up of clinical remission in juvenile idiopathic arthritis [abstract]. Arthritis
Rheum 2012;64(Suppl 10):1021.
75 Tzaribachev N, Horger M, Fritz J. Silent arthritis progression in children with
juvenile idiopathic arthritis detected by magnetic resonance imaging [abstract].
Arthritis Rheum 2011;63(Suppl 10):866.
76 Algergawy S, Haliem T, Al-Shaer O. Clinical, laboratory, and ultrasound
assessment of the knee in juvenile rheumatoid arthritis. Clin Med Insights Arthritis
Musculoskelet Disord 2011;4:21–7.
77 Cellerini M, Salti S, Trapani S, et al. Correlation between clinical and ultrasound
assessment of the knee in children with mono-articular or pauci-articular juvenile
rheumatoid arthritis. Pediatr Radiol 1999;29:117–23.
78 Frosch M, Foell D, Ganser G, et al. Arthrosonography of hip and knee joints in the
follow up of juvenile rheumatoid arthritis. Ann Rheum Dis 2003;62:242–4.
79 Janow GL, Panghaal V, Trinh A, et al. Detection of active disease in juvenile
idiopathic arthritis: sensitivity and specificity of the physical examination vs
ultrasound. J Rheumatol 2011;38:2671–4.
80 Kakati P, Sodhi KS, Sandhu MS, et al. Clinical and ultrasound assessment of the
knee in children with juvenile rheumatoid arthritis. Indian J Pediatr
2007;74:831–6.
81 Shahin AA, el-Mofty SA, el-Sheikh EA, et al. Power Doppler sonography in the
evaluation and follow-up of knee involvement in patients with juvenile idiopathic
arthritis. Z Rheumatol 2001;60:148–55.
82 Shanmugavel C, Sodhi KS, Sandhu MS, et al. Role of power Doppler sonography
in evaluation of therapeutic response of the knee in juvenile rheumatoid arthritis.
Rheumatol Int 2008;28:573–8.
83 Sureda D, Quiroga S, Arnal C, et al. Juvenile rheumatoid arthritis of the knee:
evaluation with US. Radiology 1994;190:403–6.
84 Cakmakci H, Kovanlikaya A, Unsal E. Short-term follow-up of the juvenile
rheumatoid knee with fat-saturated 3D MRI. Pediatr Radiol 2001;31:189–95.
85 Gylys-Morin VM, Graham TB, Blebea JS, et al. Knee in early juvenile rheumatoid
arthritis: MR imaging findings. Radiology 2001;220:696–706.
86 Thapa M, Spalding SJ, Hashkes PJ, et al. MRI findings from the trial of early
aggressive therapy (TREAT) study [abstract]. Pediatr Rheumatol Online J 2012;10
(Suppl 1):A36.
87 Workie DW, Graham TB, Laor T, et al. Quantitative MR characterization of disease
activity in the knee in children with juvenile idiopathic arthritis: a longitudinal pilot
study. Pediatr Radiol 2007;37:535–43.
88 Friedman S, Gruber MA. Ultrasonography of the hip in the evaluation of children
with seronegative juvenile rheumatoid arthritis. J Rheumatol 2002;29:629–32.
89 Silva V, Faquin G, Nicácio A, et al. Association between the ultrasonographic and
clinical findings in the hips of patients with juvenile idiopathic arthritis. Rev Bras
Reumatol 2013;53:322–7.
90 Argyropoulou MI, Fanis SL, Xenakis T, et al. The role of MRI in the evaluation of
hip joint disease in clinical subtypes of juvenile idiopathic arthritis. Br J Radiol
2002;75:229–33.
91 El-Azeem MIA, Taha HA, El-Sherif AM. Role of MRI in evaluation of hip joint
involvement in juvenile idiopathic arthritis. Egypt Rheumatol 2012;34:75–82.
92 Nistala K, Babar J, Johnson K, et al. Clinical assessment and core outcome
variables are poor predictors of hip arthritis diagnosed by MRI in juvenile
idiopathic arthritis. Rheumatology (Oxford) 2007;46:699–702.
93 Karmazyn B, Bowyer SL, Schmidt KM, et al. US findings of metacarpophalangeal
joints in children with idiopathic juvenile arthritis. Pediatr Radiol 2007;37:475–82.
94 Laurell L, Court-Payen M, Nielsen S, et al. Ultrasonography and color Doppler in
juvenile idiopathic arthritis: diagnosis and follow-up of ultrasound-guided steroid
injection in the wrist region. A descriptive interventional study. Pediatr Rheumatol
Online J 2012;10:11.
95 Graham TB, Laor T, Dardzinski BJ. Quantitative magnetic resonance imaging of the
hands and wrists of children with juvenile rheumatoid arthritis. J Rheumatol
2005;32:1811–20.
96 Pascoli L, Wright S, McAllister C, et al. Prospective evaluation of clinical and
ultrasound findings in ankle disease in juvenile idiopathic arthritis: importance of
ankle ultrasound. J Rheumatol 2010;37:2409–14.
97 Hendry GJ, Gardner-Medwin J, Steultjens MP, et al. Frequent discordance between
clinical and musculoskeletal ultrasound examinations of foot disease in juvenile
idiopathic arthritis. Arthritis Care Res 2012;64:441–7.
98 Laurell L, Court-Payen M, Nielsen S, et al. Ultrasonography and color Doppler in
juvenile idiopathic arthritis: diagnosis and follow-up of ultrasound-guided steroid
injection in the ankle region. A descriptive interventional study. Pediatr Rheumatol
Online J 2011;9:4.
99 Remedios D, Martin K, Kaplan G, et al. Juvenile chronic arthritis: diagnosis and
management of tibio-talar and sub-talar disease. Br J Rheumatol
1997;36:1214–17.
100 Melchiorre D, Falcini F, Kaloudi O, et al. Sonographic evaluation of the
temporomandibular joints in juvenile idiopathic arthritis. J Ultrasound
2010;13:34–7.
101 Pieroni G, Lanza C, Fabrizzi G, et al. Use of ultrasonography for the diagnosis of
temporomandibular joint disorders in children with juvenile idiopathic arthritis
[abstract]. Pediatr Radiol 2010;40:1157.
102 Abdul-Aziez OA, Saber NZ, El-Bakry SA, et al. Serum S100A12 and
temporomandibular joint magnetic resonance imaging in juvenile idiopathic
arthritis Egyptian patients: a case control study. Pak J Biol Sci 2010;13:
101–13.
103 Abramowicz S, Susarla HK, Kim S, et al. Physical findings associated with active
temporomandibular joint inflammation in children with juvenile idiopathic arthritis.
J Oral Maxillofac Surg 2013;71:1683–7.
104 Kuseler A, Pedersen TK, Gelineck J, et al. A 2 year followup study of enhanced
magnetic resonance imaging and clinical examination of the temporomandibular
joint in children with juvenile idiopathic arthritis. J Rheumatol 2005;32:162–9.
105 Mohammed Y, Saeed O, Zaghloul N, et al. Juvenile idiopathic arthritis and the
temporomandibular joint. Alexandria J Med 2012;48:123–9.
1956 Colebatch-Bourn AN, et al. Ann Rheum Dis 2015;74:1946–1957. doi:10.1136/annrheumdis-2015-207892
Recommendation
group.bmj.com on November 29, 2016 - Published by http://ard.bmj.com/Downloaded from 
106 Zwir L, Terreri MT, Sousa S, et al. Does intense synovial enhancement in
temporomandibular joints of juvenile idiopathic arthritis patients correlate with
disease activity? [abstract]. Ann Rheum Dis 2012;71(Suppl 3):264.
107 Jousse-Joulin S, Breton S, Cangemi C, et al. Ultrasonography for detecting
enthesitis in juvenile idiopathic arthritis. Arthritis Care Res 2011;63:849–55.
108 Laurell L, Court-Payen M, Nielsen S, et al. Ultrasonography and color Doppler of
proximal gluteal enthesitis in juvenile idiopathic arthritis: a descriptive study.
Pediatr Rheumatol Online J 2011;9:22.
109 Toib D, French AR, Dahiya N, et al. The role of ultrasound in B mode and power
Doppler sonography in the diagnosis of enthesitis in children [abstract]. Arthritis
Rheum 2010;62(Suppl 10):1633.
110 Rachlis AC, Babyn PS, Lobo-Mueller E, et al. Whole body magnetic resonance
imaging in juvenile spondyloarthritis: will it provide vital information compared to
clinical exam alone? [abstract]. Arthritis Rheum 2011;63(Suppl 10):749.
111 Collado P, Merino R, Grana J Sr, et al. Grey-scale ultrasonography with power
Doppler technique: An available tool for the assessment of subclinical joint
inflammatory activity in juvenile idiopathic arthritis [abstract]. Arthritis Rheum
2012;64(Suppl 10):122.
112 Haslam KE, McCann LJ, Wyatt S, et al. The detection of subclinical synovitis by
ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study. Rheumatology
(Oxford) 2010;49:123–7.
113 Jousse-Joulin S, Breton S, Cangemi C, et al. Ultrasound abnormalities of peripheral
joints in juvenile idiopathic arthritis and correlation with clinical examination
[abstract]. Arthritis Rheum 2009;60(Suppl 10):1903.
114 Sparchez M, Fodor D, Miu N. The role of Power Doppler ultrasonography in
comparison with biological markers in the evaluation of disease activity in Juvenile
Idiopathic Arthritis. Med Ultrason 2010;12:97–103.
115 Ranjan S, Jahan A, Yadav T, et al. Evaluation of synovial inflammation in juvenile
idiopathic arthritis by power color doppler and spectral doppler ultrasonography.
Indian J Pediatr 2014;81:29–35.
116 Wabi MO, Amine B, Aktaou S, et al. Ultrasonography signs in
metacarpophalangeal and metatarsophalangeal joints in children suffering from
juvenile idiopathic arthritis in Morocco: comparison of clinical evaluation [abstract].
Ann Rheum Dis 2013;72(Suppl 3):999.
117 Varshney AN, Singh NK, Shukla RC, et al. Detection of active disease by
musculoskeletal ultrasonography in patients of juvenile idiopathic arthritis
[abstract]. Indian J Rheumatol 2013;8(Suppl):1.
118 Tateishi U, Imagawa T, Kanezawa N, et al. PET assessment of disease activity in
children with juvenile idiopathic arthritis. Pediatr Radiol 2010;40:1781–8.
119 Bollow M, Biedermann T, Kannenberg J, et al. Use of dynamic magnetic
resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children
with juvenile arthritides. J Rheumatol 1998;25:556–64.
120 Susic GZ, Stojanovic RM, Pejnovic NN, et al. Analysis of disease activity, functional
disability and articular damage in patients with juvenile idiopathic arthritis:
a prospective outcome study. Clin Exp Rheumatol 2011;29:337–44.
121 Oen K, Malleson PN, Cabral DA, et al. Early predictors of longterm outcome in
patients with juvenile rheumatoid arthritis: subset-specific correlations.
J Rheumatol 2003;30:585–93.
122 Selvaag AM, Flato B, Dale K, et al. Radiographic and clinical outcome in early
juvenile rheumatoid arthritis and juvenile spondyloarthropathy: a 3-year prospective
study. J Rheumatol 2006;33:1382–91.
123 Habib HM, Mosaad YM, Youssef HM. Anti-cyclic citrullinated peptide antibodies in
patients with juvenile idiopathic arthritis. Immunol Invest 2008;37:849–57.
124 Arvidsson LZ, Fjeld MG, Smith HJ, et al. Craniofacial growth disturbance is related
to temporomandibular joint abnormality in patients with juvenile idiopathic
arthritis, but normal facial profile was also found at the 27-year follow-up. Scand J
Rheumatol 2010;39:373–9.
125 Gardner-Medwin JM, Killeen OG, Ryder CA, et al. Magnetic resonance imaging
identifies features in clinically unaffected knees predicting extension of arthritis in
children with monoarthritis. J Rheumatol 2006;33:2337–43.
Colebatch-Bourn AN, et al. Ann Rheum Dis 2015;74:1946–1957. doi:10.1136/annrheumdis-2015-207892 1957
Recommendation
group.bmj.com on November 29, 2016 - Published by http://ard.bmj.com/Downloaded from 
practice
of juvenile idiopathic arthritis in clinical
of imaging in the diagnosis and management 
EULAR-PReS points to consider for the use
and C Malattia
Rooney, N Tzaribachev, M A van Rossum, J Vojinovic, P G Conaghan
Hemke, S Jousse-Joulin, M Maas, A Martini, E Naredo, M Østergaard, M 
A N Colebatch-Bourn, C J Edwards, P Collado, M-A D'Agostino, R
doi: 10.1136/annrheumdis-2015-207892
2015
2015 74: 1946-1957 originally published online August 5,Ann Rheum Dis 
 http://ard.bmj.com/content/74/11/1946








Supplementary material can be found at: 
References
 #BIBLhttp://ard.bmj.com/content/74/11/1946
This article cites 124 articles, 31 of which you can access for free at: 
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections




 (1279)Clinical diagnostic tests
 (3253)Rheumatoid arthritis
 (4943)Musculoskeletal syndromes
 (5135)Immunology (including allergy)
 (4633)Degenerative joint disease
 (4248)Connective tissue disease
 (80)ARD Lay summaries
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on November 29, 2016 - Published by http://ard.bmj.com/Downloaded from 
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on November 29, 2016 - Published by http://ard.bmj.com/Downloaded from 
